Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
FTSE 100
7,627.20
(
0.74%
)
Dow Jones
33,093.34
(
1.0%
)
Gold vs US Dollar
1,944.825
(
-0.09%
)
Brent Oil
77.22
(
0.0%
)
Bitcoin
28,083.69
(
4.52%
)
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Physiomics Plc (PYC)

  7. Physiomics Plc (PYC) Share Price

PYC

Physiomics Plc

2.15
-0.10 (-4.44%)
Upgrade to Real-Time
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Shares Traded Last Trade
Upgrade Icon
  -0.10 -4.44% 2.15 72,130 11:23:44
Bid Price Offer Price High Price Low Price Open Price
1.80 2.50 2.25 2.00 2.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceutical Preparations 0.83 -0.25 -0.30 - 2.09
Last Trade Time Trade Type Trade Size Trade Price Currency
15:17:23 O 141 2.13 GBX
Related Shares
Smith & Nephew (SN.), Convatec (CTEC), Omega Diagnostics (ODX), Deepverge (DVRG)

Physiomics (PYC) Latest News

Physiomics News

Date Time Source Headline
23/5/202312:17ALNCNewsPhysiomics shares drop after it cuts full-year guidance
23/5/202307:28ALNCNews*Physiomics expects to recognise income from delayed contracts next..
23/5/202307:00UKREGPhysiomics PLC Trading Update
09/5/202307:00RNSNONPhysiomics PLC Publication of article in Frontiers in Oncology
26/4/202314:32ALNCNewsTRADING UPDATES: Narf Industries audit delay; Arecor wins patent
26/4/202307:00UKREGPhysiomics PLC Collaborative Services Agreement
14/4/202307:00RNSNONPhysiomics PLC Physiomics to present at AACR Annual Meeting
04/4/202310:47ALNCNewsPhysiomics shares drop as laments lack of funding for biotechnology
04/4/202310:24ALNCNewsAIM WINNERS & LOSERS: Light Science shares plummet on fundraise
04/4/202307:00UKREGPhysiomics PLC Trading and Company Update

Physiomics (PYC) Discussions and Chat

Physiomics Forums and Chat

Date Time Title Posts
27/5/202320:49Physiomics - Cancer Treatment tech firm working with Merck + Oxford Uni10,775
17/6/202107:23PHYSIOMICS plc Virtual Tumor platform4,957
28/3/202122:05Physiomics PYC 2021 DISCUSSION (MODERATED)5
22/12/202011:363 Years ago today2
29/11/202014:533 Years ago today-

Add a New Thread

Physiomics (PYC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Physiomics (PYC) Top Chat Posts

Top Posts
Posted at 14/4/2023 12:00 by davevt
Tmk it's just public relations. Do you think the scientists who work on actual drugs only know about stuff by going to a conference?

It's a bit like when pyc do a stand at a show with some banners. Surely if the bod had been doing their job, every pharma out there should already know about pyc and what they do...or do you think these big companies are walking around conferences, stumble across pycs stand and say 'ooh, I never heard of you, Im interested in this product'.

It's not the ideal home show..
Read Full Thread
Follow
Reply
Posted at 06/4/2023 09:53 by davevt
The only reason idiots invest is because they have no idea what a basic simple service pyc does, and they don't realise pyc pretty much have a set menu pricing for each drug they model...and it's not much.

Pyc is like a window cleaner that cleans windows and charges £50 per house. The only way it can make more money, is more customers. The clowns seem to think they may stumble across a billionaire who for some reason wants to pay them millions to clean his windows..
Read Full Thread
Follow
Reply
Posted at 04/4/2023 18:10 by base7
Any chance of PYC being acquired by Val to put PYC shareholders out of our misery & allow deluded Val shareholders to believe that PYCs acitivities would enhance their recently established lab
Read Full Thread
Follow
Reply
Posted at 03/2/2023 15:19 by tees maar khan
How about you scroll up and take a look at that chart? Unless the share price drops below 3p. I think you won't be the one having the last laugh here.

After the little consolidation period is over, it's going skywards. Double-figure share price.

TMK
Read Full Thread
Follow
Reply
Posted at 01/2/2023 00:12 by tees maar khan
C'mon davevt, you're telling me that all these companies using their services and expertise are stupid? Testimonials of the good work and praise from Cellcentric, Bicycle Therapeutics, Numab Therapeutics, Merck KGaA etc.

The company doesn't raise funds like confetti. The grants are used to fund projects. Namely the NIHR grant which funded the PARTNER study observational trial.

They've only recently started to expand the team. I think this is in aid of the strong pipeline.

The work with Cancer Research UK. Updates due on the projects this quarter. I seriously think you need to take another look at the company.

Why would they be loss making? It's because they've made deliberate investments with regards to their PR, marketing spend and business development plans. The risk sharing agreements with VAL didn't quite pan out. The Tabula Rasa situation with the commercial revenue generating agreement didn't happen. Of course I'm going to mention covid happened as well. The company has done well to contend with the headwinds.

It was 2p and now the share price is 4p. That's progress. Albeit slow progress, it's still progress.

The share price is consolidating and with further updates expected, it could easily continue higher after this brief period of inactivity. There's lots to research with regards to Project Optimus. There may even be some collaboration in the works. A lot is happening. All you keep crying about is the past 20 years.

Look to the future and please give it a rest man.

TMK
Read Full Thread
Follow
Reply
Posted at 31/1/2023 17:37 by tees maar khan
It will just take one unexpected RNS to land and it will spike to 10p in a flash.

You know full well how rapidly the PYC share price can rise. Not only that, your pupils will dilate and your heart rate will also rise as you watch in total astonishment. Don't count out Dr Jim Millen and Physiomics just yet.

TMK
Read Full Thread
Follow
Reply
Posted at 31/1/2023 16:50 by tees maar khan
PYC share price can hit 10p before davevt can say where did the rise even come from. Master RSI seems to be losing his touch. That Golden Cross is inept. It hasn't played out on this occasion.

TMK
Read Full Thread
Follow
Reply
Posted at 11/12/2022 14:24 by tees maar khan
Avenue_of_Revenue, don't let them rile you up. A share price has to fall to rise. These things are beyond Terminator101 and davevt's understanding or comprehension. The involvement with Bicycle and Numab is favourable for Physiomics in the longer term. Not sure how the risk sharing agreements with VAL and SAR are going to pan out. Hopefully they can build a strong relationship with Servier, as they have done with Merck over the years. Things are looking a lot better for Physiomics.

I think the whole strongest ever pipeline talk needs to be unpacked. Which may start to happen subsequently after the PARTNER study observational trial results.

Whether the share price continues to rise or retraces. This is too cheap and doesn't warrant a single digit share price and market cap.

TMK
Read Full Thread
Follow
Reply
Posted at 09/12/2022 16:49 by davevt
Blackbear, The cancer uk project will be around pycs usual pricing of £35k.

This is why pyc stopped mentioning value in their rns, they used to mention it in every single one, because the low prices pyc charge made the share price drop after every rns.
Read Full Thread
Follow
Reply
Posted at 10/11/2022 15:43 by davevt
Laura's really going for it..

'Pyc work in a multi billion pound cancer sector , (SO DO WINDOW CLEANERS) they are working with 20 or more well known global pharmaceutical companies with huge budgets (IRRELEVANT AS PYC DICTATE THE COST AND EVEN THEY SAID THE SIZE OF THE CLIENT HAS NO RELEVANCE TO THE FEE)
.
PYC are only listed comapny in UK who can save time and money for designing oncology drugs using computer modeling (OUTRIGHT LIE, IN FACT PYC ARE THE LEAST COMPETENT OUT OF ALL THE LISTED BIOTECHS DOING DOSE MODELLING...PYC DO NOT 'DEVELOP DRUGS',THEY WORK OUT THE BEST DOSE OF A DRUG THAT'S ALREADY BEEN DEVELOPED)

The £2.5 million marker value is ludicrous given pyc have loads of cash and record revenues approaching £1mln per year'(WHO CARES HOW MUCH CASH THEY HAVE WHEN IT IS CONSTANTLY BEING EATEN INTO WITH CONSTANT LOSSES. SO WHAT IF THEY HAVE ENOUGH MONEY FOR 2 YEARS, THIS MEANS IN 2 YEARS THEY WON'T 🤣
Read Full Thread
Follow
Reply
Physiomics share price data is direct from the London Stock Exchange
Your Recent History
LSE
PYC
Physiomics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230528 22:40:21